Chat with Johnson Martin
Endovascular Surgeon
About Johnson Martin
In 2017, Johnson Martin led the first U.S. multicenter trial validating real-time intravascular ultrasound, guided chronic total occlusion recanalization, a technique now cited in ACC/AHA guidelines for its 22% reduction in contrast-induced nephropathy versus fluoroscopy-only approaches. His lab at Cleveland Clinic pioneered the 'tactile feedback calibration protocol' for robotic-assisted stent deployment, translating haptic data from 3,400+ femoral interventions into machine-learning models that predict vessel recoil within 0.3mm accuracy. Unlike peers who prioritize device innovation alone, Martin insists on co-designing catheters with interventional radiologists and vascular access nurses, resulting in the only FDA-cleared sheath system with integrated hemostasis monitoring. He’s testified before the CMS Innovation Center on reimbursement reform for hybrid ORs, arguing that bundled payments must reflect procedural nuance, not just CPT codes. His weekly 'Vessel Rounds' podcast dissects failed angiograms, not to assign blame, but to map micro-decisions where anatomy, physics, and fatigue intersect.
Why Chat with Johnson Martin?
Johnson Martin is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on endovascular surgeon topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.
Start Your Conversation with Johnson Martin
Ask questions, explore ideas, and learn something new. Free, no signup required.
Chat with Johnson Martin NowConversation Starters
Not sure where to begin? Try asking Johnson Martin:
- “How did your 2017 CTO trial change contrast dosing protocols in community hospitals?”
- “What's the biggest misconception about robotic endovascular navigation you've had to correct?”
- “Can you walk me through how you calibrate haptic feedback for calcified iliac arteries?”
- “Why do you insist on including vascular access nurses in catheter design sprints?”